These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2874692)

  • 21. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
    Coulombe D
    Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New positive inotropic agents for congestive heart failure.
    N Engl J Med; 1986 Aug; 315(6):396-7. PubMed ID: 3736614
    [No Abstract]   [Full Text] [Related]  

  • 23. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new inotropic phosphodiesterase inhibitors.
    el Allaf D; D'Orio V; Carlier J
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S69-79. PubMed ID: 6085243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 26. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R; De Marino V; Marino A
    Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New inotropic drugs].
    Presbitero P; Chiotti D
    Cardiologia; 1988 Aug; 33(8):747-53. PubMed ID: 2904301
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE
    Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General overview and update of positive inotropic therapy.
    Leier CV
    Am J Med; 1986 Oct; 81(4C):40-5. PubMed ID: 2946223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
    Shevchenko VA
    Vrach Delo; 1983 Oct; (10):8-12. PubMed ID: 6139918
    [No Abstract]   [Full Text] [Related]  

  • 33. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs.
    Harrison SA; Chang ML; Beavo JA
    Circulation; 1986 Mar; 73(3 Pt 2):III109-16. PubMed ID: 3002661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Present use of positive inotropic drugs in heart failure.
    Schlepper M; Thormann J; Kremer P; Mitrovic V; Kramer W
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S9-19. PubMed ID: 2480492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
    Sfrisi C; Cocco G
    Clin Ter; 1984 Oct; 111(2):159-67. PubMed ID: 6239739
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
    Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of the positive inotropic effect of phosphodiesterase inhibitors].
    Scholz H; Dieterich HA; Schmitz W
    Z Kardiol; 1991; 80 Suppl 4():1-6. PubMed ID: 1656618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.